PEDF在癌症中的各种作用
Mitra Elmi1,2, Joshua H Dass1,3, Crispin R Dass1,2
1Curtin Medical School, Curtin University, Bentley, WA 6102, Australia.
Cancers
|February 10, 2024
概括
颜料表皮衍生因子 (PEDF) 是一种具有抗癌和促癌作用的天然化合物. 本综述探讨了如何测量转移性和代谢性生物标志物可以帮助理解PEDF.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 颜料表皮衍生因子 (PEDF) 具有多方面的作用,作为天然免疫调节剂,抗炎症,抗血管新生和抗转移剂.
- 虽然PEDF可以增强抗瘤反应,但它也可能具有促癌效应,突出显示了与癌症进展的复杂关系.
- 炎症被认为是癌症发展的重要因素,而PEDF已确定的抗炎性质是其研究的核心.
研究的目的:
- 审查色素上皮质衍生因子 (PEDF) 在癌症中的双重作用,检查其治疗潜力和不良影响.
- 讨论测量转移性和代谢生物标志物的实用性,以阐明PEDF在癌症背景下的功能活性.
主要方法:
- 本综述综合了有关色素上皮质衍生因子 (PEDF) 和其对癌症的影响的现有文献.
- 通过分析特定的生物标志物,重点研究PEDF的功能活动.
- 探讨炎症,PEDF和癌症进展之间的联系.
主要成果:
- 颜料上皮质衍生因子 (PEDF) 显示出显著的抗炎性质,可能抵消癌症的关键驱动因素.
- PEDF的活动可能取决于环境,导致抗瘤或促癌的结果.
- 转移性和代谢性生物标志物对于评估PEDF对瘤行为的净影响至关重要.
结论:
- 了解色素上皮质衍生因子 (PEDF) 的精确机制是至关重要的,因为它对癌症具有复杂且有时相互矛盾的作用.
- 测量转移和代谢生物标志物提供了一种可行的方法来研究PEDF的功能活性和治疗潜力.
- 对PEDF的作用进行进一步的研究是有必要的,以利用其抗癌特性,同时减轻潜在的风险.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


